June 26, 2020 / 10:10 IST
Reported Standalone quarterly numbers for Bafna Pharmaceuticals are:Net Sales at Rs 13.13 crore in March 2020 up 38.32% from Rs. 9.49 crore in March 2019.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.16 crore in March 2020 up 98.96% from Rs. 15.06 crore in March 2019.
EBITDA stands at Rs. 3.57 crore in March 2020 up 128.36% from Rs. 12.59 crore in March 2019.
Bafna Pharma shares closed at 3.55 on August 23, 2019 (NSE)
| Bafna Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | | Net Sales/Income from operations | 13.13 | 10.93 | 9.49 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 13.13 | 10.93 | 9.49 | | EXPENDITURE | | Consumption of Raw Materials | 6.41 | 8.05 | 7.42 | | Purchase of Traded Goods | -- | 0.02 | 0.16 | | Increase/Decrease in Stocks | -1.72 | -0.94 | 1.39 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.08 | 2.42 | 2.67 | | Depreciation | 0.52 | 1.00 | 0.77 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.12 | 1.15 | 10.73 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.72 | -0.78 | -13.64 | | Other Income | -0.67 | 0.03 | 0.29 | | P/L Before Int., Excpt. Items & Tax | 3.05 | -0.75 | -13.36 | | Interest | 0.03 | -0.10 | 0.21 | | P/L Before Exceptional Items & Tax | 3.03 | -0.65 | -13.57 | | Exceptional Items | -1.61 | -21.72 | -- | | P/L Before Tax | 1.42 | -22.36 | -13.57 | | Tax | 1.58 | -0.04 | 1.49 | | P/L After Tax from Ordinary Activities | -0.16 | -22.33 | -15.06 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.16 | -22.33 | -15.06 | | Equity Share Capital | 2.37 | 23.66 | 23.66 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.66 | -94.39 | -6.37 | | Diluted EPS | -0.66 | -94.30 | -6.37 | | EPS After Extra Ordinary | | Basic EPS | -0.66 | -94.39 | -6.37 | | Diluted EPS | -0.66 | -94.30 | -6.37 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
